FDA Bans Safer & Cheaper Bio-Identical Hormone Therapy

Disclosure: This post asks you to take 10 minutes of your time and help a good cause that could restrict FDA’s flaunting and mis-using its power. Read on…

1. The Problem: FDA Takes Action Against Compounded Menopause Hormone Therapy Drugs

The Federal Drug Administration (FDA) has limited the rights of women to seek natural hormone alternatives instead of synthetic drugs (which are created from horse urine). Compounded drugs are specifically personalized to each patient by their doctor and carefully prepared by licensed pharmacists. The chemicals used in these compounds are molecularly identical to hormones produced by the human body. They are usually safer too. But yet the FDA has banned them.

2. The Start of the Problem

Wyeth Pharmaceuticals makes Premarin and Prempro – synthetic drugs.

A study funded by the National Institutes of Health specifically linked these two drugs to increased risk of stroke, breast cancer, and heart attack. As a result, sales of these 2 drugs dropped by 68%! The beneficiaries were compounded natural hormone therapy drugs.

So Wyeth Pharmaceuticals responds by sending a “citizens petition” to the FDA requesting action against natural hormonal therapy for women.

3. The FDA Bias to Take Bad Action

In an unprecedented ethical conflict of interest, the FDA receives a cut (called drug user fees) from the pharmaceutical companies based on the number of drugs they sell. Since the states and not the federal government regulate compounding pharmacies, they don’t have to pay the FDA.

And because natural hormones cannot be patented, there is comparatively little financial incentive to the drug companies to bring them to the market.

So despite an outpouring of support for natural hormonal therapy from doctors, patients and pharmacists the FDA heeded to Wyeth Pharmaceuticals citizens petition and made the move to ban bio-identical hormone therapy.

4. Is There a Solution to This FDA Problem?

In a key first step toward reigning in the FDA’s actions against women’s health, Congress has introduced House Concurrent Resolution 342 and Senate Concurrent Resolution 88. This resolution calls upon the FDA to stop their new policy of restricting women’s access to prescriptions containing estriol, a natural hormone that has been prescribed for women in the US for over 20 years.

So What Can You Do To Help?

  • Write your senators and congressmen.
  • Send letters to your local newspaper. (You can send this post along with your letter too.)
  • Ask your friends and family to get involved.
  • The Health Freedom Foundation has made this easy for you at http://ga4.org/campaign/Estriol_Resolution


  • Please send this post to your friends.
  • Vote for it at StumbleUpon.com and other social media websites and help us spread the message.
FDA Bans Safer & Cheaper Bio-Identical Hormone Therapy was last modified: by

Leave a Comment